Global HPV Genotype Assay Market Growth 2025-2031

The global HPV Genotype Assay market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

HPV genotyping identifies specific viral types of HPV. It is useful for triage in cervical cancer screening and the evaluation of HPV vaccination effects.

United States market for HPV Genotype Assay is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for HPV Genotype Assay is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for HPV Genotype Assay is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key HPV Genotype Assay players cover Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “HPV Genotype Assay Industry Forecast” looks at past sales and reviews total world HPV Genotype Assay sales in 2024, providing a comprehensive analysis by region and market sector of projected HPV Genotype Assay sales for 2025 through 2031. With HPV Genotype Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HPV Genotype Assay industry.

This Insight Report provides a comprehensive analysis of the global HPV Genotype Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HPV Genotype Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HPV Genotype Assay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HPV Genotype Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HPV Genotype Assay.

This report presents a comprehensive overview, market shares, and growth opportunities of HPV Genotype Assay market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Membrane Hybridization
Fluorescence PCR
Others

Segmentation by Application:
Hospital
Centers for Disease Control and Prevention
Third-party Diagnostic Agency
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
Hybribio
CapitalBio
YanengBIO
Liferiver
Tellgen
AID GmbH

Key Questions Addressed in this Report

What is the 10-year outlook for the global HPV Genotype Assay market?

What factors are driving HPV Genotype Assay market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do HPV Genotype Assay market opportunities vary by end market size?

How does HPV Genotype Assay break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.